Lawsuit Overview - A class action lawsuit has been filed against Metagenomi Inc on behalf of investors who acquired its securities between February 9 2024 and May 1 2024 [1] - Investors have until November 25 2024 to apply to be appointed as lead plaintiff in the lawsuit [1] IPO and Stock Performance - Metagenomi conducted its IPO on February 12 2024 selling approximately 6 25 million shares at $15 per share [1] - On May 1 2024 Metagenomi announced the termination of its collaboration with Moderna leading to a 12 4% decline in share price from $7 04 to $6 17 [1] Allegations in the Lawsuit - The lawsuit alleges that Metagenomi's IPO registration statements were false and/or materially misleading [2] - Metagenomi represented itself as having a long-standing business relationship with Moderna but the collaboration was terminated shortly after the IPO [2] Law Firm Information - Kirby McInerney LLP is handling the lawsuit and has a history of recovering billions of dollars for shareholders in securities litigation [3]
MGX INVESTOR ALERT: Kirby McInerney LLP Reminds Metagenomi Inc. Investors of Deadline in Class Action Lawsuit